Determination of spiropyran cytotoxicity by high content screening and analysis for safe application in bionanosensing

Chemical Research in Toxicology

Volumn 23, Issue 9, 2010, Pages 1459-1466

  Movia, Dania ^a   Prina Mello, Adriele ^a   Volkov, Yuri ^a,b   Giordani, Silvia ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

1',3' DIHYDRO 1' ETHANOL 3',3' DIMETHYL 8 METHOXY 6 NITRO SPIRO(2H 1 BENZOPYRAN 2,2' (2H)INDOLE; INTERLEUKIN 6; PYRAN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BIONANOSENSING; CANCER CELL CULTURE; CELL LOSS; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; NANOBIOTECHNOLOGY; RISK ASSESSMENT; SCREENING;

BENZOPYRANS; BIOSENSING TECHNIQUES; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; HUMANS; INDOLES; INTERLEUKIN-6; NANOTECHNOLOGY; NITRO COMPOUNDS; SPIRO COMPOUNDS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956894275     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100123g     Document Type: Article

References (32)

1. Fischer, E. and Hirshberg, Y. (1952) Formation of colored forms of spiropyrans by low-temperature irradiation. J. Chem. Soc. 4522-4524
2. Raymo, F. M. and Giordani, S. (2001) Signal Processing at the Molecular Level J. Am. Chem. Soc. 123, 4651-4652
3. Raymo, F. M., Giordani, S., White, A. J. P., and Williams, D. J. (2003) Digital processing with a three-state molecular switch J. Org. Chem. 68, 4158-4169
4. Giordani, S. and Raymo, F. M. (2003) A switch in a cage with a memory Org. Lett. 5, 3559-3562
5. Natali, M., Aakeroy, C. B., Desper, J., and Giordani, S. (2010) The role of metal ions and counterions in the switching behavior of a carboxylic acid functionalized spiropyran. Dalton Trans. 39, 8269-8277.
6. Marriott, G., Mao, S., Sakata, T., Ran, J., Jackson, D. K., Petchprayoon, C., Gomez, T. J., Warp, E., Tulyathan, O., Aaron, H. L., Isacoff, E. Y., and Yan, Y. L. (2008) Optical lock-in detection imaging microscopy for contrast-enhanced imaging in living cells Proc. Natl. Acad. Sci. U.S.A. 105, 17789-17794
7. Mao, S., Benninger, R. K. P., Yan, Y. L., Petchprayoon, C., Jackson, D., Easley, C. J., Piston, D. W., and Marriott, G. (2008) Optical lock-in detection of FRET using synthetic and genetically encoded optical switches Biophys. J. 94, 4515-4524
8. Seefeldt, B., Kasper, R., Beining, M., Mattay, J., Arden-Jacob, J., Kemnitzer, N., Drexhage, K. H., Heilemann, M. and, and Sauer, M. Spiropyrans as molecular optical switches Photochem. Photobiol. Sci. 9, 213-220
9. Astier, Y., Bayley, H., and Howorka, S. (2005) Protein components for nanodevices Curr. Opin. Chem. Biol. 9, 576-584
10. Kocer, A., Walko, M., Meijberg, W., and Feringa, B. L. (2005) A light-actuated nanovalve derived from a channel protein Science 309, 755-758
11. Yoshida, M. and Lahann, J. (2008) Smart nanomaterials ACS Nano 2, 1101-1107
12. Browne, W. R. and Feringa, B. L. (2006) Making molecular machines work Nat. Nanotechnol. 1, 25-35
13. Commission of the European Communities (2009) Nanosciences and Nanotechnologies: An action plan for Europe 2005-2009. Second Implementation Report 2007-2009, Commission of the European Communities.
14. -(2006) DIRECTIVE 2006/121/EC, Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
15. OECD (2008) Current developments/activities on the safety of manufactured nanomaterials, in Environment, Health and Safety Publications: Series on the Safety of Manufactured Nanomaterials, OECD Environmental Directorate, Paris, France.
16. Stafforst, T. and Hilvert, D. (2009) Kinetic characterization of spiropyrans in aqueous media Chem. Commun. 287-288
17. Aakeroy, C. B., Hurley, E. P., Desper, J., Natali, M., Douglawi, A., and Giordani, S. (2010) The balance between closed and open forms of spiropyrans in the solid state Cryst. Eng. Commun. 12, 1027-1033
18. Dowling, A., Clift, R., Grobert, N., Hutton, D., Oliver, R., O'Neill, O., Pethica, J., Pidgeon, N., Porritt, J., Ryan, J., Seaton, A., Tendler, S., Welland, M., and Whatmore, R. (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties, Royal Society and Royal Academy of Engineering, London, UK.
19. Abraham, V. C., Taylor, D. L., and Haskins, J. R. (2004) High content screening applied to large-scale cell biology Trends Biotechnol. 22, 15-22
20. Davies, A. M., Volkov, Y., and Spiers, J. P. (2008) Drug discovery automation: development of cardiac cell based assays to study drug efficacy and toxicity Screening-Trends Drug Discovery 9, 21-24
21. Giuliano, K. A., Haskins, J. R., and Taylor, D. L. (2003) Advances in high content screening for drug discovery Assay Drug Dev. Technol. 1, 565-577
22. Abraham, V. C., Towne, D. L., Waring, J. E., Warrior, U., and Burns, D. J. (2008) Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans J. Biomol. Screening 13, 527-537
23. Williams, Y., Sukhanova, A., Nowostawska, M., Davies, A. M., Mitchell, S., Oleinikov, V., Gun'ko, Y., Nabiev, I., Kelleher, D., and Volkov, Y. (2009) Probing cell-type-specific intracellular nanoscale barriers using size-tuned quantum dots Small 5, 2581-2588
24. Jan, E., Byrne, S. J., Cuddihy, M., Davies, A. M., Volkov, Y., Gun'ko, Y. K., and Kotov, N. A. (2008) High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles ACS Nano 2, 928-938
25. George, S., Pokhrel, S., Xia, T., Gilbert, B., Ji, Z. X., Schowalter, M., Rosenauer, A., Damoiseaux, R., Bradley, K. A., Madler, L., and Nel, A. E. (2010) Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping ACS Nano 4, 15-29
26. Byrne, F., Prina-Mello, A., Whelan, A., Mohamed, B. M., Davies, A., Gun'ko, Y. K., Coey, J. M. D., and Volkov, Y. (2009) High content analysis of the biocompatibility of nickel nanowires J. Magn. Magn. Mater. 321, 1341-1345
27. O'Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., Brain, P., and Hougham, C. (2006) High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Arch. Toxicol. 80, 580-604
28. Mingeot-Leclercq, M. P., Brasseur, R., and Schanck, A. (1995) Molecular-parameters involved in aminoglycoside nephrotoxicity J. Toxicol. Environ. Health 44, 263-300
29. Reasor, M. J. (1989) A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs Toxicol. Appl. Pharmacol. 97, 47-56
30. Schins, R. P. F., Lightbody, J. H., Borm, P. J. A., Shi, T., Donaldson, K., and Stone, V. (2004) Inflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituents Toxicol. Appl. Pharmacol. 195, 1-11
31. Jones, C. F. and Grainger, D. W. (2009) In vitro assessments of nanomaterial toxicity Adv. Drug Delivery Rev. 61, 438-456
32. Kishimoto, T., Akira, S., and Taga, T. (1992) Interleukin-6 and its receptor: A paradigm for cytokines Science 258, 593-597